Endo Appoints New CMO
This article was originally published in Scrip
Endo International Plc has named Craig Paterson chief medical officer. Paterson will be responsible for the company's global clinical development strategies and lifecycle management. Before joining Endo, Paterson was senior vice-president of medical and clinical development for Salix Pharmaceuticals and he has held roles within medical and clinical development at GlaxoSmithKline plc and King Pharmaceuticals, a wholly owned subsidiary of Pfizer Inc.